Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
12.97
+0.16 (1.25%)
Nov 5, 2024, 4:00 PM EST - Market closed
Immunome Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$28.75
Upside
+121.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +154.43% | Oct 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $27 → $23 | Buy | Maintains | $27 → $23 | +77.33% | Aug 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +154.43% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $27 | Buy | Initiates | $27 | +108.17% | May 31, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $24 | Buy | Initiates | $24 | +85.04% | Apr 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +169.85% | Apr 15, 2024 |
| Wedbush | Wedbush | Buy Maintains $27 → $33 | Buy | Maintains | $27 → $33 | +154.43% | Apr 1, 2024 |
| Wedbush | Wedbush | Buy Maintains $12 → $19 | Buy | Maintains | $12 → $19 | +46.49% | Jan 23, 2024 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | -7.48% | Dec 19, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | -38.32% | Mar 20, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | -38.32% | Mar 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $35 | Buy | Initiates | $35 | +169.85% | Oct 29, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +38.78% | Oct 27, 2020 |